Concepts (309)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria | 49 | 2023 | 1239 | 8.460 |
Why?
|
Nigeria | 73 | 2023 | 733 | 5.320 |
Why?
|
Antimalarials | 32 | 2022 | 905 | 5.120 |
Why?
|
Artemisinins | 15 | 2020 | 221 | 2.210 |
Why?
|
Diagnostic Tests, Routine | 15 | 2022 | 783 | 1.850 |
Why?
|
Pregnancy Complications, Parasitic | 5 | 2022 | 54 | 1.590 |
Why?
|
Rural Population | 13 | 2021 | 2210 | 1.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 14 | 2021 | 3923 | 1.160 |
Why?
|
Health Personnel | 12 | 2022 | 3218 | 1.160 |
Why?
|
Prenatal Care | 7 | 2022 | 1092 | 0.950 |
Why?
|
Parasitemia | 6 | 2022 | 174 | 0.910 |
Why?
|
Mothers | 7 | 2021 | 2165 | 0.850 |
Why?
|
Urban Population | 4 | 2020 | 2021 | 0.850 |
Why?
|
Fever | 9 | 2022 | 1616 | 0.840 |
Why?
|
Drug Combinations | 8 | 2020 | 1959 | 0.820 |
Why?
|
Operations Research | 2 | 2018 | 23 | 0.810 |
Why?
|
Health Education | 5 | 2011 | 1056 | 0.790 |
Why?
|
Cross-Sectional Studies | 37 | 2023 | 25043 | 0.740 |
Why?
|
Laboratories, Hospital | 1 | 2022 | 194 | 0.740 |
Why?
|
Insecticide-Treated Bednets | 5 | 2022 | 64 | 0.730 |
Why?
|
Prediabetic State | 2 | 2023 | 499 | 0.710 |
Why?
|
Ethanolamines | 3 | 2008 | 158 | 0.700 |
Why?
|
Nonprescription Drugs | 1 | 2020 | 116 | 0.690 |
Why?
|
Fluorenes | 3 | 2008 | 160 | 0.660 |
Why?
|
Needs Assessment | 3 | 2021 | 1147 | 0.660 |
Why?
|
Pharmacies | 1 | 2020 | 150 | 0.650 |
Why?
|
Home Nursing | 2 | 2008 | 92 | 0.630 |
Why?
|
Dental Health Surveys | 1 | 2017 | 43 | 0.630 |
Why?
|
Amodiaquine | 4 | 2019 | 61 | 0.610 |
Why?
|
Communicable Disease Control | 3 | 2021 | 857 | 0.610 |
Why?
|
Transients and Migrants | 1 | 2020 | 155 | 0.600 |
Why?
|
Case Management | 6 | 2021 | 286 | 0.600 |
Why?
|
Tooth Diseases | 1 | 2017 | 77 | 0.600 |
Why?
|
Laboratories | 3 | 2019 | 463 | 0.570 |
Why?
|
Perception | 2 | 2021 | 1198 | 0.560 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2022 | 810 | 0.520 |
Why?
|
Patient Acceptance of Health Care | 5 | 2020 | 3022 | 0.510 |
Why?
|
Hypertension | 5 | 2023 | 8480 | 0.490 |
Why?
|
Caregivers | 8 | 2020 | 2094 | 0.490 |
Why?
|
Clinical Protocols | 1 | 2020 | 1462 | 0.470 |
Why?
|
Uganda | 11 | 2016 | 1243 | 0.460 |
Why?
|
Epidemics | 1 | 2019 | 523 | 0.450 |
Why?
|
Primary Prevention | 1 | 2020 | 1167 | 0.440 |
Why?
|
Sulfadoxine | 3 | 2019 | 49 | 0.430 |
Why?
|
Preventive Health Services | 1 | 2017 | 575 | 0.430 |
Why?
|
Pyrimethamine | 3 | 2019 | 97 | 0.430 |
Why?
|
Oral Health | 1 | 2017 | 472 | 0.420 |
Why?
|
Hospitals, Teaching | 1 | 2017 | 1179 | 0.420 |
Why?
|
Adult | 52 | 2023 | 214055 | 0.410 |
Why?
|
Patients | 1 | 2017 | 900 | 0.370 |
Why?
|
Female | 69 | 2023 | 380194 | 0.370 |
Why?
|
Burkina Faso | 7 | 2016 | 88 | 0.360 |
Why?
|
Health Services Research | 4 | 2021 | 1836 | 0.350 |
Why?
|
Medication Adherence | 2 | 2019 | 2063 | 0.350 |
Why?
|
Research Design | 2 | 2023 | 5987 | 0.340 |
Why?
|
Child, Preschool | 23 | 2023 | 41006 | 0.340 |
Why?
|
Health Facilities | 6 | 2020 | 573 | 0.340 |
Why?
|
Research | 1 | 2017 | 1999 | 0.330 |
Why?
|
Humans | 89 | 2023 | 744343 | 0.330 |
Why?
|
Audiovisual Aids | 1 | 2008 | 92 | 0.310 |
Why?
|
Prevalence | 12 | 2023 | 15226 | 0.310 |
Why?
|
Male | 55 | 2023 | 350118 | 0.310 |
Why?
|
Young Adult | 28 | 2022 | 56430 | 0.290 |
Why?
|
Delivery of Health Care | 4 | 2022 | 5319 | 0.290 |
Why?
|
Community-Based Participatory Research | 1 | 2008 | 214 | 0.290 |
Why?
|
Appointments and Schedules | 2 | 2019 | 417 | 0.290 |
Why?
|
Residence Characteristics | 1 | 2016 | 2050 | 0.280 |
Why?
|
Immunization Programs | 2 | 2021 | 260 | 0.280 |
Why?
|
Middle Aged | 35 | 2023 | 213383 | 0.280 |
Why?
|
Drug Prescriptions | 4 | 2020 | 1637 | 0.270 |
Why?
|
Practice Guidelines as Topic | 4 | 2020 | 7279 | 0.260 |
Why?
|
Infant | 17 | 2023 | 35136 | 0.260 |
Why?
|
Africa South of the Sahara | 7 | 2020 | 724 | 0.250 |
Why?
|
Program Development | 3 | 2021 | 1316 | 0.240 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2538 | 0.240 |
Why?
|
Echinococcus granulosus | 1 | 2023 | 10 | 0.240 |
Why?
|
Laboratory Personnel | 2 | 2022 | 19 | 0.240 |
Why?
|
Echinococcosis | 1 | 2023 | 30 | 0.240 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2016 | 2026 | 0.230 |
Why?
|
Mosquito Control | 3 | 2022 | 104 | 0.230 |
Why?
|
Local Government | 2 | 2021 | 80 | 0.220 |
Why?
|
Chloroquine | 4 | 2008 | 280 | 0.220 |
Why?
|
Sputum | 2 | 2022 | 476 | 0.210 |
Why?
|
Microbiological Techniques | 2 | 2020 | 102 | 0.210 |
Why?
|
Drug Therapy, Combination | 4 | 2020 | 6489 | 0.210 |
Why?
|
Microscopy | 4 | 2018 | 903 | 0.210 |
Why?
|
Malaria, Falciparum | 2 | 2023 | 1077 | 0.210 |
Why?
|
Focus Groups | 5 | 2019 | 1321 | 0.200 |
Why?
|
Socioeconomic Factors | 7 | 2020 | 7785 | 0.200 |
Why?
|
Pregnancy | 12 | 2022 | 29144 | 0.200 |
Why?
|
Program Evaluation | 2 | 2021 | 2488 | 0.200 |
Why?
|
Tetanus Toxoid | 1 | 2021 | 193 | 0.200 |
Why?
|
Cities | 1 | 2023 | 513 | 0.190 |
Why?
|
Patient Compliance | 5 | 2019 | 2684 | 0.190 |
Why?
|
Guideline Adherence | 3 | 2020 | 2266 | 0.190 |
Why?
|
Epidemiology | 2 | 2014 | 287 | 0.190 |
Why?
|
HIV Infections | 3 | 2022 | 16718 | 0.190 |
Why?
|
Overweight | 3 | 2022 | 2371 | 0.180 |
Why?
|
Child | 15 | 2023 | 77709 | 0.180 |
Why?
|
Logistic Models | 7 | 2019 | 13408 | 0.180 |
Why?
|
Ambulatory Care Facilities | 2 | 2019 | 933 | 0.180 |
Why?
|
Employee Performance Appraisal | 1 | 2020 | 87 | 0.170 |
Why?
|
Immunization | 2 | 2021 | 1256 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 11725 | 0.170 |
Why?
|
Attitude to Health | 1 | 2008 | 2052 | 0.170 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2019 | 224 | 0.160 |
Why?
|
DMF Index | 1 | 2017 | 90 | 0.160 |
Why?
|
Sentinel Surveillance | 1 | 2020 | 281 | 0.150 |
Why?
|
Tanzania | 3 | 2016 | 1346 | 0.150 |
Why?
|
Public Health | 3 | 2017 | 2603 | 0.150 |
Why?
|
Democratic Republic of the Congo | 1 | 2017 | 88 | 0.150 |
Why?
|
Capacity Building | 1 | 2020 | 248 | 0.150 |
Why?
|
Inservice Training | 1 | 2020 | 392 | 0.150 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4933 | 0.150 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
Knowledge | 1 | 2018 | 181 | 0.150 |
Why?
|
Personal Satisfaction | 1 | 2021 | 643 | 0.140 |
Why?
|
Heart Failure | 1 | 2021 | 10900 | 0.140 |
Why?
|
Postnatal Care | 1 | 2019 | 236 | 0.140 |
Why?
|
Qualitative Research | 2 | 2020 | 2682 | 0.140 |
Why?
|
Obesity | 3 | 2023 | 12745 | 0.140 |
Why?
|
Accidents | 1 | 2017 | 164 | 0.140 |
Why?
|
Twins | 1 | 2018 | 339 | 0.140 |
Why?
|
Case-Control Studies | 4 | 2022 | 21746 | 0.140 |
Why?
|
Age Distribution | 3 | 2017 | 2902 | 0.140 |
Why?
|
Inappropriate Prescribing | 1 | 2018 | 202 | 0.140 |
Why?
|
Fast Foods | 1 | 2018 | 197 | 0.130 |
Why?
|
Reminder Systems | 1 | 2019 | 371 | 0.130 |
Why?
|
Adolescent | 15 | 2022 | 85781 | 0.130 |
Why?
|
Rural Health Services | 2 | 2009 | 379 | 0.130 |
Why?
|
Breast Diseases | 1 | 2018 | 443 | 0.130 |
Why?
|
Urbanization | 1 | 2015 | 104 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2022 | 972 | 0.120 |
Why?
|
Poultry | 1 | 2014 | 82 | 0.120 |
Why?
|
Outpatients | 1 | 2002 | 1486 | 0.120 |
Why?
|
South Africa | 2 | 2016 | 1731 | 0.120 |
Why?
|
Influenza in Birds | 1 | 2014 | 75 | 0.120 |
Why?
|
Risk Factors | 12 | 2023 | 72290 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2019 | 738 | 0.120 |
Why?
|
Blood Pressure | 2 | 2022 | 8554 | 0.110 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2014 | 113 | 0.110 |
Why?
|
Maternal Health Services | 1 | 2019 | 455 | 0.110 |
Why?
|
Occupations | 1 | 2015 | 517 | 0.110 |
Why?
|
Administration, Rectal | 3 | 2016 | 73 | 0.110 |
Why?
|
Disease Outbreaks | 2 | 2020 | 1772 | 0.110 |
Why?
|
Counseling | 1 | 2020 | 1523 | 0.100 |
Why?
|
Infant, Newborn | 6 | 2020 | 25625 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 676 | 0.100 |
Why?
|
Violence | 1 | 2017 | 909 | 0.100 |
Why?
|
Administration, Oral | 2 | 2016 | 3913 | 0.100 |
Why?
|
Mycobacterium tuberculosis | 1 | 2022 | 1832 | 0.100 |
Why?
|
Disease Transmission, Infectious | 1 | 2016 | 547 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3176 | 0.090 |
Why?
|
Antitubercular Agents | 1 | 2019 | 1320 | 0.090 |
Why?
|
Refugees | 1 | 2017 | 511 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2020 | 1796 | 0.090 |
Why?
|
Commerce | 1 | 2014 | 592 | 0.080 |
Why?
|
Interviews as Topic | 3 | 2014 | 2539 | 0.080 |
Why?
|
Directly Observed Therapy | 2 | 2019 | 137 | 0.080 |
Why?
|
Community Medicine | 1 | 2008 | 25 | 0.080 |
Why?
|
Chemoprevention | 1 | 2011 | 319 | 0.080 |
Why?
|
Awareness | 1 | 2013 | 640 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2008 | 5078 | 0.080 |
Why?
|
Sepsis | 1 | 2022 | 2593 | 0.080 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 3843 | 0.080 |
Why?
|
Vaccines | 1 | 2016 | 822 | 0.080 |
Why?
|
Insurance, Health | 1 | 2020 | 2494 | 0.080 |
Why?
|
Morphine | 1 | 2012 | 657 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2023 | 14722 | 0.070 |
Why?
|
Family Characteristics | 3 | 2018 | 1000 | 0.070 |
Why?
|
Health Expenditures | 1 | 2020 | 2348 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15165 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2016 | 3528 | 0.070 |
Why?
|
Educational Status | 2 | 2017 | 2540 | 0.070 |
Why?
|
Ghana | 1 | 2008 | 286 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 40075 | 0.070 |
Why?
|
Child Development | 1 | 2018 | 2223 | 0.070 |
Why?
|
Tuberculosis | 1 | 2019 | 1912 | 0.070 |
Why?
|
Blood | 1 | 2008 | 598 | 0.070 |
Why?
|
Government Programs | 1 | 2008 | 275 | 0.070 |
Why?
|
Selection, Genetic | 2 | 2007 | 914 | 0.070 |
Why?
|
Hospitals | 1 | 2019 | 3952 | 0.070 |
Why?
|
Exercise | 1 | 2022 | 5615 | 0.070 |
Why?
|
Feeding Behavior | 1 | 2018 | 3188 | 0.060 |
Why?
|
Wounds and Injuries | 1 | 2017 | 2400 | 0.060 |
Why?
|
Geography | 3 | 2014 | 669 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 3966 | 0.060 |
Why?
|
Interview, Psychological | 1 | 2008 | 812 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2020 | 3508 | 0.060 |
Why?
|
Mass Screening | 1 | 2020 | 5255 | 0.060 |
Why?
|
Pregnancy Complications | 1 | 2018 | 2861 | 0.060 |
Why?
|
Health Services Accessibility | 4 | 2020 | 5137 | 0.060 |
Why?
|
Haplotypes | 2 | 2007 | 2779 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3278 | 0.060 |
Why?
|
Antibodies, Helminth | 1 | 2023 | 50 | 0.060 |
Why?
|
HIV-1 | 1 | 2022 | 6939 | 0.060 |
Why?
|
Body Mass Index | 2 | 2023 | 12720 | 0.060 |
Why?
|
Cultural Characteristics | 1 | 2005 | 262 | 0.060 |
Why?
|
Pilot Projects | 3 | 2017 | 8324 | 0.050 |
Why?
|
Health Surveys | 3 | 2019 | 4037 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2023 | 401 | 0.050 |
Why?
|
Mammography | 1 | 2013 | 2476 | 0.050 |
Why?
|
Proteins | 1 | 2016 | 6103 | 0.050 |
Why?
|
Developing Countries | 3 | 2020 | 2815 | 0.050 |
Why?
|
Universal Precautions | 1 | 2020 | 34 | 0.050 |
Why?
|
Obesity, Abdominal | 1 | 2023 | 361 | 0.050 |
Why?
|
Chronic Disease | 1 | 2015 | 9146 | 0.050 |
Why?
|
Needlestick Injuries | 1 | 2020 | 67 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2002 | 392 | 0.040 |
Why?
|
Diet | 1 | 2018 | 7939 | 0.040 |
Why?
|
Disease Notification | 1 | 2020 | 97 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6171 | 0.040 |
Why?
|
Dogs | 1 | 2023 | 3912 | 0.040 |
Why?
|
Primary Health Care | 2 | 2019 | 4558 | 0.040 |
Why?
|
Cohort Studies | 3 | 2023 | 40561 | 0.040 |
Why?
|
Palpation | 1 | 2018 | 167 | 0.040 |
Why?
|
Body Fluids | 1 | 2020 | 319 | 0.040 |
Why?
|
Palliative Care | 1 | 2013 | 3493 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2012 | 5317 | 0.040 |
Why?
|
Contact Tracing | 1 | 2020 | 273 | 0.040 |
Why?
|
Pregnancy Trimesters | 1 | 2019 | 192 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5751 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39050 | 0.040 |
Why?
|
Poliovirus Vaccine, Oral | 1 | 2016 | 28 | 0.040 |
Why?
|
Ethiopia | 1 | 2019 | 495 | 0.040 |
Why?
|
Pain | 1 | 2012 | 4986 | 0.040 |
Why?
|
Ultrasonography, Mammary | 1 | 2018 | 250 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2002 | 2971 | 0.030 |
Why?
|
Measles Vaccine | 1 | 2016 | 76 | 0.030 |
Why?
|
Aged | 6 | 2017 | 163280 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 1 | 2018 | 571 | 0.030 |
Why?
|
Estradiol | 1 | 2023 | 2020 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2018 | 981 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2012 | 3674 | 0.030 |
Why?
|
Prehypertension | 1 | 2015 | 61 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2022 | 2715 | 0.030 |
Why?
|
Education, Veterinary | 1 | 2014 | 7 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2019 | 63114 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 265 | 0.030 |
Why?
|
Rural Health | 1 | 2016 | 305 | 0.030 |
Why?
|
Postmenopause | 1 | 2023 | 2461 | 0.030 |
Why?
|
Genome, Human | 1 | 2007 | 4420 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2014 | 131 | 0.030 |
Why?
|
Government Agencies | 1 | 2014 | 156 | 0.030 |
Why?
|
Plasmodium falciparum | 1 | 2023 | 1732 | 0.030 |
Why?
|
Population Surveillance | 2 | 2014 | 2616 | 0.030 |
Why?
|
Urban Health | 1 | 2016 | 547 | 0.030 |
Why?
|
Breast Self-Examination | 1 | 2013 | 34 | 0.030 |
Why?
|
Private Sector | 1 | 2016 | 392 | 0.030 |
Why?
|
Education, Professional | 1 | 2013 | 54 | 0.030 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2020 | 1320 | 0.030 |
Why?
|
Communications Media | 1 | 2013 | 43 | 0.030 |
Why?
|
Students | 1 | 2022 | 1654 | 0.030 |
Why?
|
Community Networks | 1 | 2014 | 203 | 0.030 |
Why?
|
Physical Examination | 1 | 2018 | 1237 | 0.030 |
Why?
|
Drug Resistance | 1 | 2018 | 1609 | 0.030 |
Why?
|
Postpartum Period | 1 | 2018 | 1086 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2007 | 15519 | 0.020 |
Why?
|
Pregnant Women | 1 | 2016 | 568 | 0.020 |
Why?
|
Africa | 1 | 2013 | 673 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2114 | 0.020 |
Why?
|
Health Priorities | 1 | 2014 | 380 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15076 | 0.020 |
Why?
|
Sex Distribution | 1 | 2015 | 2297 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3396 | 0.020 |
Why?
|
Animals | 4 | 2023 | 168757 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 764 | 0.020 |
Why?
|
Specimen Handling | 1 | 2014 | 694 | 0.020 |
Why?
|
Breast | 1 | 2018 | 1969 | 0.020 |
Why?
|
Goals | 1 | 2014 | 706 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2017 | 77449 | 0.020 |
Why?
|
Edar Receptor | 1 | 2007 | 24 | 0.020 |
Why?
|
Teaching | 1 | 2015 | 1174 | 0.020 |
Why?
|
International Cooperation | 1 | 2014 | 1420 | 0.020 |
Why?
|
Quality Improvement | 1 | 2022 | 3749 | 0.020 |
Why?
|
Prospective Studies | 3 | 2019 | 53288 | 0.020 |
Why?
|
Motivation | 1 | 2016 | 1971 | 0.020 |
Why?
|
Antiporters | 1 | 2007 | 277 | 0.020 |
Why?
|
Nurses | 1 | 2015 | 2461 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9849 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2013 | 20822 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15540 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7181 | 0.010 |
Why?
|
Self Administration | 1 | 2005 | 385 | 0.010 |
Why?
|
Health Behavior | 1 | 2015 | 2636 | 0.010 |
Why?
|
Homozygote | 1 | 2007 | 1785 | 0.010 |
Why?
|
Neoplasms | 1 | 2012 | 21683 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 2007 | 1997 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2007 | 1586 | 0.010 |
Why?
|
Genetics, Population | 1 | 2007 | 934 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13989 | 0.010 |
Why?
|
Family | 1 | 2013 | 3147 | 0.010 |
Why?
|
Fathers | 1 | 2005 | 358 | 0.010 |
Why?
|
Pain Measurement | 1 | 2012 | 3420 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
Communication Barriers | 1 | 2005 | 398 | 0.010 |
Why?
|
Cause of Death | 1 | 2012 | 3584 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9959 | 0.010 |
Why?
|
Mental Health | 1 | 2015 | 3019 | 0.010 |
Why?
|
Gene Frequency | 1 | 2007 | 3588 | 0.010 |
Why?
|
Health Promotion | 1 | 2013 | 2205 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3846 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 19905 | 0.010 |
Why?
|
Causality | 1 | 2005 | 1275 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2013 | 57776 | 0.010 |
Why?
|
Models, Molecular | 1 | 2007 | 5456 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3341 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17446 | 0.010 |
Why?
|
United States | 1 | 2014 | 69872 | 0.000 |
Why?
|
Concepts
(309)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_